MX2013014485A - Vacuna bovinas y metodos. - Google Patents

Vacuna bovinas y metodos.

Info

Publication number
MX2013014485A
MX2013014485A MX2013014485A MX2013014485A MX2013014485A MX 2013014485 A MX2013014485 A MX 2013014485A MX 2013014485 A MX2013014485 A MX 2013014485A MX 2013014485 A MX2013014485 A MX 2013014485A MX 2013014485 A MX2013014485 A MX 2013014485A
Authority
MX
Mexico
Prior art keywords
methods
bovis
hardjo
animal
infection
Prior art date
Application number
MX2013014485A
Other languages
English (en)
Other versions
MX345704B (es
Inventor
Eric Springer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2013014485A publication Critical patent/MX2013014485A/es
Publication of MX345704B publication Critical patent/MX345704B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Abstract

Se describen métodos para estimular respuestas inmunes en un animal bovino susceptible a infección por Leptospira hardjo-bovis. En los métodos, se administra una composición de L. hardjo-bovis inactivado y un adyuvante al animal en aproximadamente 4 semanas desde el nacimiento. Las respuestas inmunes estimuladas en el animal previenen o acortan la duración de una posterior infección por L. hardjo-bovis. La respuesta inmune es eficaz durante al menos un año.
MX2013014485A 2011-06-10 2012-06-08 Vacuna bovinas y métodos. MX345704B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161495591P 2011-06-10 2011-06-10
PCT/US2012/041443 WO2012170753A2 (en) 2011-06-10 2012-06-08 Bovine vaccines and methods

Publications (2)

Publication Number Publication Date
MX2013014485A true MX2013014485A (es) 2014-03-21
MX345704B MX345704B (es) 2017-02-10

Family

ID=47296754

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013014485A MX345704B (es) 2011-06-10 2012-06-08 Vacuna bovinas y métodos.

Country Status (6)

Country Link
US (1) US9364527B2 (es)
CA (1) CA2836805C (es)
CO (1) CO6870003A2 (es)
MX (1) MX345704B (es)
PE (1) PE20140576A1 (es)
WO (1) WO2012170753A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3578205A1 (en) 2010-08-06 2019-12-11 ModernaTX, Inc. A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
NZ608972A (en) 2010-10-01 2015-09-25 Moderna Therapeutics Inc Engineered nucleic acids and methods of use thereof
US8710200B2 (en) 2011-03-31 2014-04-29 Moderna Therapeutics, Inc. Engineered nucleic acids encoding a modified erythropoietin and their expression
CN110201187A (zh) 2011-12-16 2019-09-06 现代泰克斯公司 经修饰的核苷、核苷酸和核酸组合物
US10501512B2 (en) 2012-04-02 2019-12-10 Modernatx, Inc. Modified polynucleotides
AU2013243952A1 (en) 2012-04-02 2014-10-30 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
EP2885419A4 (en) 2012-08-14 2016-05-25 Moderna Therapeutics Inc ENZYMES AND POLYMERASES FOR RNA SYNTHESIS
PT2922554T (pt) 2012-11-26 2022-06-28 Modernatx Inc Arn modificado nas porções terminais
US20160024181A1 (en) 2013-03-13 2016-01-28 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
US10258698B2 (en) 2013-03-14 2019-04-16 Modernatx, Inc. Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
WO2015048744A2 (en) 2013-09-30 2015-04-02 Moderna Therapeutics, Inc. Polynucleotides encoding immune modulating polypeptides
EP3359670B2 (en) 2015-10-05 2024-02-14 ModernaTX, Inc. Methods for therapeutic administration of messenger ribonucleic acid drugs
WO2017132146A1 (en) 2016-01-25 2017-08-03 Zdenko Grajcar Biosecurity system for an agricultural dwelling

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ501213A (en) * 1998-12-22 2001-09-28 Pfizer Prod Inc Isolated leptospira membrane kinase, membrane permease, membrane mannosyltransferase and endoflagellin proteins for preventing leptospirosis
ATE533506T1 (de) * 2002-08-26 2011-12-15 Pfizer Prod Inc Impfstoff gegen das fortpflanzungs- und atmungssyndrom bei rindern
US7563449B2 (en) * 2003-04-21 2009-07-21 Pfizer Inc, Methods for reducing cattle reproductive diseases
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
CN104758929B (zh) * 2008-06-27 2018-05-25 硕腾有限责任公司 新颖的佐剂组合物

Also Published As

Publication number Publication date
CO6870003A2 (es) 2014-02-20
WO2012170753A3 (en) 2014-05-08
MX345704B (es) 2017-02-10
WO2012170753A2 (en) 2012-12-13
CA2836805A1 (en) 2012-12-13
PE20140576A1 (es) 2014-05-24
US9364527B2 (en) 2016-06-14
US20140105930A1 (en) 2014-04-17
CA2836805C (en) 2023-03-07

Similar Documents

Publication Publication Date Title
MX2013014485A (es) Vacuna bovinas y metodos.
MX2021001762A (es) Metodo y composicion para estimular la respuesta inmunitaria.
PH12014501835A1 (en) Novel adjuvant compositions
MX2013012219A (es) Método de administración de vacunas.
NZ715459A (en) A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same
BR112014007657A2 (pt) dispositivos médicos implantáveis com tolerância imune aperfeiçoada e métodos para produção e implantação
NZ731659A (en) Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
WO2013188627A3 (en) Cationic lipid vaccine compositions and methods of use
PH12015501716A1 (en) Anti-mycoplasma spp. subunit vaccine
UA114286C2 (uk) Спосіб лікування staphylococcus aureus
IN2015KN00516A (es)
PH12015502844A1 (en) Mammalian milk osteopontin for enhancing immune responsiveness
WO2015051371A3 (en) Haemophilus parasuis vaccine serovar type four
MX2015017257A (es) Composiciones y metodos de inmunizar contra clostridium difficile.
EP4316497A3 (en) Mesenchymal stem cells as vaccine adjuvants and methods for using the same
NZ720498A (en) Stress management in livestock
GB201104897D0 (en) Method for the production of protein complexes and vaccine compositions comprising the same
RU2011108858A (ru) Средство для повышения роста и сохранности молодняка
WO2016018454A3 (en) Compositions and methods employing bcl2 and bcl2 family members
IN2012DN04875A (es)
UA64867U (ru) Способ лечения пиелонефритов у беременных
UA65561U (ru) Способ профилактики задержания помета у коров
UA74219U (ru) Способ стимулирования противогриппозного иммунитета
RU2015118636A (ru) Тени бактерий L. casei 583 для стимулирования врожденного иммунного ответа и их применение
RU2015118633A (ru) Тени бактерий L. casei 577 для стимулирования врожденного иммунного ответа и их применение

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: NOVARTIS TIERGESUNDHEIT AG

FG Grant or registration